Time Schedule
Tuesday, 10th April 2012 07:00 – 08:00: Breakfast / Registration / 08:00 – 08:25: Acute Coronary Syndrome Management: Current Challenges and Emerging Solutions / 08:25 – 08:50: Drug Eluting Stent: An Update on Clinical Data / 08:50 – 09:15: Antiplatelet Strategies in Acute Coronary Syndrome: Expanding Choices / 09:15 – 09:25: Discussion / 09:25 – 10:00: Official Opening Ceremony / 10:00 – 10:25: Anticoagulant in ACS and Beyond / 10:25 – 10:50: Newer Antiplatelet: Confronting the Limitations of Antiplatelet Therapy / 10:50 – 11:15: Risk of Bleeding: Balancing Risk and Benefit / 11:15 – 11:25: Discussion / 11:25 – 11:35: Break / 11:35 – 12:00: Heart Failure: Current Medical Therapy / 12:00 – 12:25: Heart Rate as a Therapeutic Target in Heart Failure Patients / 12:25 – 12:50: Devices and Technology in the Management of Heart Failure / 12:50 – 13:00: Discussion / 13:00 – 14:00: Prayer Time, Lunch Break, Exhibition / 14:00 – 14:25: Update on Hypertension Management / 14:25 – 14:50: JNC 8 (VIII): What new is going to be in the guidelines? / 14:50 – 15:15: Strategies for the Management of Resistant Hypertension / 15:15-15:25: Discussion / 15:25-15:40: Break, Prayer Time / 15:40 – 16:05: Medication safety concerns in the cardiovascular patient / 16:05 – 16:30: Lipid management: Optimizing Therapies Old and New / 16:30 – 16:55: Primary prevention of cardiovascular disease: Tools and Strategies / 16:55-17:05: Discussion / Wednesday, 11th April 2012 07:00 –08:00: Breakfast / Registration / 08:00 –08:25: Contemporary approach in Atrial Fibrillation Management / 08:25 –08:50: Antithrombotic Therapy in Afib: Defining the future of Oral Anticoagulant Therapy / 08:50 –09:15: Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management / 09:15 –09:25: Discussion / 09:25 –09:40: Break / 09:40 –10:05: ICU Management of End Stage Heart Failure and Mechanical Circulatory Support Therapy / 10:05 –10:30: Heart Transplant: indication, selection, pre and post op care / 10:30 –10:55: Long Term Management of Heart Transplant and the Pharmacist Role / 10:55 –11:05: Discussion / 11:05 –11:20: Break / 11:20 –11:45: VTE: Acute and Chronic Management / 11:45 –12:10: Contemporary Management of VHD in Various Medical Settings / 12:10 –12:35: Transcatheter Aortic Valve Implantation (TAVI): Highlight on Procedural and Pharmacotherapy Management Implications / 12:35 –12:45: Discussion / 12:45 –14:00: Prayer Time, Lunch Break, Exhibition / 14:00 –14:25: Antiplatelet resistant / un-responsiveness: Genomic Markers and Advanced Testing / 14:25 –14:50: Tailored antiplatelet therapy: Pharmacogenomics or Dynamic Applications / 14:50 –15:15: Women cardiology: Differences in Diagnosis and Management / 15:15-15:25: Discussion / 15:25-15:40: Break, Prayer Time / 15:40 –16:05: Update on Peripheral Arterial Disease (PAD) Management Guidelines / 16:05 –16:30: Reducing Cardiovascular disease globally through combination approaches to prevention: the polypill / 16:30 –16:55: Ectatic Coronary Arteries management :where are we now / 16:55-17:05: Discussion
Slider

IDr. Fahad Al-Kharjit is a great pleasure as well as an honor for me to invite you to participate in the 2nd International Cardiovascular Pharmacotherapy Conference & Exhibition which will be held between 10-11 April, 2012 at Four Seasons Hotel, Kingdom Center in Riyadh, Saudi Arabia. under -Maj Gen. Dr.Ketab Al-Otaibi,the director of Department of Medical Services of Armed Forces.

This is the only Cardiovascular Pharmacotherapy Conference in Saudi Arabia and one of the specialized cardiac pharmacotherapy in the Middle East. It is organized by the Pharmacy Department of Prince Sultan Cardiac Center, which will strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact cardiovascular clinical practice.

In addition we have added a social program, gala dinner and sightseeing tours for the international speakers with the organizing & scientific committee members. During the month of April, the weather in Riyadh is excellent with a temperature ranging between 25 and 30 degrees Celsius. The venue is Four Season Hotel for conference and the exhibition and is considered the best conference venue in the kingdom and attached to the, Al-Mamlakah Tower, Riyadh.

We look forward to welcoming you in the 2nd International Cardiovascular Pharmacotherapy Conference & Exhibition, Riyadh. Saudi Arabia

Best Regards

Dr. Fahad Al-Kharji

Chairman of the Organizing Committee

Sponsors